Norlutate

Norlutate^® (Norethindrone Acetate) is a progestin indicated to treat amenorrhea, endometriosis and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as submucous fibroids or uterine cancer. Norlutate^®  is approved by Health Canada and is available with a valid prescription.

Erfa provides relevant information on Norlutate^® to patients and health care professionals. Visit our frequently asked questions (FAQ). Register in our forum and subscribe to our mailing list in order to get the latest news and releases on our products.

® Registred Trademark of Erfa Sciences Inc. Used under license by Erfa Canada Inc. Montréal, CANADA